Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Saft

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Experimental Neurology|December 30, 2008
Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system: evidence from event-related potentialsChristian Beste, Carsten Konrad, Carsten Saft, et al.
BMC Neurology|November 17, 2011
Hepatic mitochondrial dysfunction in Friedreich ataxiaSven H Stüwe, Oliver Goetze, Larissa Arning, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2017
Progressive spinal cord atrophy in manifest and premanifest Huntington's diseaseWeike Wilhelms, Barbara Bellenberg, Odo Köster, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2014
Cross sectional PET study of cerebral adenosine A₁ receptors in premanifest and manifest Huntington's diseaseAndreas Matusch, Carsten Saft, David Elmenhorst, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2006
Mutations in TITF1 are not relevant to sporadic and familial chorea of unknown causePeter Bauer, Friedmar R Kreuz, Katrin Bürk, et al.
Brain and Behavior|May 5, 2022
No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onsetRahel Dominique Schmid, Jana Remlinger, Mathias Abegg, et al.
Experimental Neurology|January 9, 2018
Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's diseaseOluwaseun Fatoba, Eugen Kloster, Christiane Reick, et al.
Human Brain Mapping|May 15, 2007
Levels of error processing in Huntington's disease: a combined study using event-related potentials and voxel-based morphometryChristian Beste, Carsten Saft, Carsten Konrad, et al.
Journal of Huntington'S Disease|March 23, 2018
Cannabinoids for Treatment of Dystonia in Huntington's DiseaseCarsten Saft, Sarah Maria von Hein, Thomas Lücke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2004
Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HDJürgen Andrich, Carsten Saft, Anneliese Arz, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Experimental Neurology|December 30, 2008
Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system: evidence from event-related potentialsChristian Beste, Carsten Konrad, Carsten Saft, et al.
BMC Neurology|November 17, 2011
Hepatic mitochondrial dysfunction in Friedreich ataxiaSven H Stüwe, Oliver Goetze, Larissa Arning, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2017
Progressive spinal cord atrophy in manifest and premanifest Huntington's diseaseWeike Wilhelms, Barbara Bellenberg, Odo Köster, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2014
Cross sectional PET study of cerebral adenosine A₁ receptors in premanifest and manifest Huntington's diseaseAndreas Matusch, Carsten Saft, David Elmenhorst, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2006
Mutations in TITF1 are not relevant to sporadic and familial chorea of unknown causePeter Bauer, Friedmar R Kreuz, Katrin Bürk, et al.
Brain and Behavior|May 5, 2022
No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onsetRahel Dominique Schmid, Jana Remlinger, Mathias Abegg, et al.
Experimental Neurology|January 9, 2018
Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's diseaseOluwaseun Fatoba, Eugen Kloster, Christiane Reick, et al.
Human Brain Mapping|May 15, 2007
Levels of error processing in Huntington's disease: a combined study using event-related potentials and voxel-based morphometryChristian Beste, Carsten Saft, Carsten Konrad, et al.
Journal of Huntington'S Disease|March 23, 2018
Cannabinoids for Treatment of Dystonia in Huntington's DiseaseCarsten Saft, Sarah Maria von Hein, Thomas Lücke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2004
Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HDJürgen Andrich, Carsten Saft, Anneliese Arz, et al.
Pageof 15